Looking for CALR mutations in familial myeloproliferative neoplasms

被引：18
|
作者：
Maffioli, M. [1 ]
Genoni, A. [2 ]
Caramazza, D. [1 ]
Mora, B. [1 ]
Bussini, A. [2 ]
Merli, M. [1 ]
Giorgino, T. [3 ]
Casalone, R. [2 ]
Passamonti, F. [1 ]
机构：
[1] Univ Hosp Osped Circolo & Fdn Macchi, Dept Med, Div Hematol, Varese, Italy
[2] Univ Hosp Osped Circolo & Fdn Macchi, Med Genet & Cytogenet Lab, Genet Unit, SSD,SMEL, Varese, Italy
[3] Natl Res Council Italy ISIB CNR, Inst Biomed Engn, Padua, Italy
来源：
LEUKEMIA | 2014年 / 28卷 / 06期
关键词：
ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; TET2; GENE; MYELOFIBROSIS; JAK2; DISORDERS;
D O I：
10.1038/leu.2014.33
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1357 / 1360
页数：5
相关论文
共 50 条
  • [31] CALR mutations in myeloproliferative neoplasms induce unfolded protein response and resistance to ER stress
    Wildschut, Thijs
    van Oostrum, Marc
    Schurch, Patrick
    Wilhelm, Thomas
    Vannucchi, Alessandro
    Huber, Michael
    Wollscheid, Bernd
    Theocharides, Alexandre
    SWISS MEDICAL WEEKLY, 2018, 148 : 18S - 19S
  • [32] CAL2 Immunohistochemical Staining Accurately Identifies CALR Mutations in Myeloproliferative Neoplasms
    Nomani, Laila
    Bodo, Juraj
    Zhao, Xiaoxian
    Durkin, Lisa
    Loghavi, Sanam
    Hsi, Eric D.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146 (04) : 431 - 438
  • [33] Germline RBBP6 mutations in familial myeloproliferative neoplasms
    Harutyunyan, Ashot S.
    Giambruno, Roberto
    Krendl, Christian
    Stukalov, Alexey
    Klampfl, Thorsten
    Berg, Tiina
    Chen, Doris
    Feenstra, Jelena D. Milosevic
    Jaeger, Roland
    Gisslinger, Bettina
    Gisslinger, Heinz
    Rumi, Elisa
    Passamonti, Francesco
    Pietra, Daniela
    Mueller, Andre C.
    Parapatics, Katja
    Breitwieser, Florian P.
    Herrmann, Richard
    Colinge, Jacques
    Bennett, Keiryn L.
    Superti-Furga, Giulio
    Cazzola, Mario
    Hammond, Emma
    Kralovics, Robert
    BLOOD, 2016, 127 (03) : 362 - 365
  • [34] Identification of Concurrent JAK2 and CALR Mutations and a Novel 9bp CALR Deletion in Myeloproliferative Neoplasms
    Murugesan, G.
    Guenther-Johnson, J.
    Mularo, F.
    Schneider, K.
    Cook, J. R.
    Daly, T. M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 843 - 844
  • [35] Mutations in JAK2, MPL and CALR in myeloproliferative neoplasms: High Resolution Melting analysis
    Paola Videla, Yanina
    Quintana, Silvina
    Perez Maturo, Josefina
    Di Geronimo, Vanesa
    Martin, Nazarena
    Pagani, Fernando
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2017, 51 (04): : 629 - 636
  • [36] Clinicopathologic Analysis of Calr Mutation Subtypes in Myeloproliferative Neoplasms
    Xu, Yin
    Kwok, Brian
    Yung, Aine
    Flamholz, Rachel
    Wu, Zhao
    Dabbas, Bashar
    Reddy, Prashanti
    BLOOD, 2015, 126 (23)
  • [37] The Contemporary Approach to CALR-Positive Myeloproliferative Neoplasms
    Belcic Mikic, Tanja
    Pajic, Tadej
    Zver, Samo
    Sever, Matjaz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (07)
  • [38] AKT activation is a feature of CALR mutant myeloproliferative neoplasms
    Chunling Fu
    Qiang Jeremy Wen
    Christian Marinaccio
    Te Ling
    Wei Chen
    Marinka Bulic
    Terra Lasho
    Ayalew Tefferi
    John D. Crispino
    Kailin Xu
    Leukemia, 2019, 33 : 271 - 274
  • [39] AKT activation is a feature of CALR mutant myeloproliferative neoplasms
    Fu, Chunling
    Wen, Qiang Jeremy
    Marinaccio, Christian
    Ling, Te
    Chen, Wei
    Bulic, Marinka
    Lasho, Terra
    Tefferi, Ayalew
    Crispino, John D.
    Xu, Kailin
    LEUKEMIA, 2019, 33 (01) : 271 - 274
  • [40] Familial Chronic Myeloproliferative Neoplasms
    Alati, Caterina
    Martino, Bruno
    Marino, Antonio
    Ronco, Francesca
    Priolo, Manuela
    Nobile, Francesco
    BLOOD, 2010, 116 (21) : 1269 - 1269
12345